After Hours Summary: URBN +2% following comps update, BA higher following dividend / buyback news -- and despite reports of additional 777 cuts... INOV -33%, PAY -4.5% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: URBN +2.1% (discloses thus far during the fourth quarter comparable Retail segment net sales are low single-digit positive)
Companies trading higher in after hours in reaction to news: APRI +20.1% (continued strength following ~50% move higher), ABUS +11.9% (reports new results from the ongoing Phase II study of ARB-1467 in chronically infected HBV patients on stable nucleos(t)ide therapy), BA +1.8% (increases quarterly dividend to $1.42/share from $1.09/share; replaces existing share repurchase program with a new $14 billion authorization), NVCR +1.7% (will present data from its phase 2 pilot PANOVA clinical trial at its R&D day on Dec. 12 suggesting that TTFields plus first-line chemotherapies nab-paclitaxel and gemcitabine may be tolerable and safe in patients with advanced pancreatic cancer)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: INOV -33% (lowers FY16 guidance due to inability to enter into expected collaboration agreement as a result of unforeseen circumstances impacting counter-party), PPHM -12%, PAY -4.5%, WWE -3% (light volume - raised the low end of its projected range of average paid WWE Network subs for Q4 and reaffirmed its 2016 adj. OIBDA and Operating income guidance; to offer $175 mln convertible senior notes due 2023 in a private placement)
Companies trading lower in after hours in reaction to news: AKAO -7.7% (following ~150% move higher; commences 5.75 mln common stock offering), NSA -3.4% (commences an underwritten public offering of 4,500,000 common shares of beneficial interest of the Company), ARI -2.6% (commences 10.5 mln share common stock offering), MIK -2.3% (Michaels Stores announces secondary offering of 12 mln shares of common stock by selling stockholders and repurchase by the company of a portion of such common stock), RPRX -2% (announces it has requested a meeting to discuss Phase 3 requirements for the development of Proellex for the treatment of symptomatic uterine fibroids; anticipates meeting in 1H of 2017), STAY -1.9% (announces secondary offering and repurchase of paired shares), UNVR -1.6% (files for common stock shelf offering by selling shareholders; commences 12.5 mln common stock offering by selling stockholders, investment funds affiliated with Clayton, Dubilier & Rice and Dahlia Investments), WFC -0.3% (ticking lower; California Department of Insurance investigating allegations against Wells Fargo)